|
Match
|
Document |
Document Title |
|
|
5434166 |
Methods of inhibiting demyelinating and desmyelinating diseases
A method of inhibiting demyelinating or dysmyelinating diseases or their symptoms comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR1##...
|
|
|
5430024 |
Peptides bearing N-terminal amidino moieties and their use as inhibitors of platelet aggregation
Acetic acid derivatives of formula H 2 N(NH)C--X--Y--CO--Z--CH(Q 1 )COOQ 2 I and hydrates, solvates and physiologically acceptable salts thereof are useful to inhibit the binding of...
|
|
|
5424309 |
N-substituted acylamino acid compounds, process for their production and their use
The present invention provides an N-substituted acylamino acid compound of the formula: ##STR1## a process for their production and pharmaceutical uses, and intermediates useful for their production.
|
|
|
5420164 |
Cycloalkylurea compounds
A cycloalkylurea compound of the formula (I): ##STR1## wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, which compound inhibits ACAT and is...
|
|
|
5418252 |
Method for inhibiting cartilage degradation
A method of inhibiting cartilage degradation comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula ##STR1## wherein R 1 and...
|
|
|
5411933 |
Bromopropargyl quarternary ammonium compounds having antimicrobial activity
Antimicrobial compounds of the formula ##STR1## wherein R, R 1 and R 2 are selected according to the following: A. R is (C 11 -C 16 ) alkyl (straight or branched), and R 1 and R 2 are...
|
|
|
5411970 |
Method of inhibiting lentivirus
A method of inhibiting lentivirus is disclosed which comprises mammalian host susceptible to said lentivirus with a virally inhibitory effective amount of an O-acylated derivative of...
|
|
|
5399589 |
Oxalyl hydrazide-hydroxamic acid derivatives, their preparation and their use as fungicides
Oxalyl hydrazide-hydroxamic acid derivatives of the formula I ##STR1## where the substituents have the following meanings: R, R 1 , R 2 and R 3 independently of one another are hydrogen,...
|
|
|
5399567 |
Method of treating cholera
This invention discloses a method of treating cholera infection in a human by administering an effective amount of 1,5-dideoxy-1,5-imino-D-glucitol or a derivative thereof.
|
|
|
5393754 |
Organophosphorus compounds, and insecticides, acaricides and nematocides containing same
Insecticidal, acaricidal or nematocidal compositions which comprise a series of organophosphorus compounds represented by the following representative structural formulae: ##STR1## show excellent...
|
|
|
5393762 |
Pharmaceutical agents for treatment of emesis
The present invention relates to a method of treating or preventing emesis in mammals, including humans, using certain quinuclidine derivatives, piperidine derivatives, azanorbornane derivatives...
|
|
|
5385918 |
Aminomethylene-peptides as immunosuppressants
Compounds which suppress human T-lymphocyte proliferation are disclosed. The active compounds essentially contain at least the following structure: ##STR1## wherein A, R 1 , R 2 , R 3 , n, X 1 and...
|
|
|
5385902 |
Iodopropargylated oxalic derivatives as antimicrobial agents
Antimicrobial compounds of the formula ##STR1## wherein A is selected from the group consisting of alkyl; phenyl; alkoxy; phenoxy; benzyloxy; monoalkylamino; dialkylamino; cyclic amino, anilino;...
|
|
|
5382588 |
Methyl piperidine derivatives of cinnamic acids, benzoic acids, benzoazols and benzophenones useful as skin anti-aging compounds
Free radical deactivating 4- or 1,4-substituted, 2,2,6,6-tetramethyl piperidines are condensed with UV absorbing cinnamic acids or benzoic acids or benzoazols or benzophenones to produce skin...
|
|
|
5366997 |
Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
There are disclosed cardiovascularly active compounds possessing antihypertensive properties, and pharmaceutical compositions containing these agents and a method of treating cardiovascular...
|
|
|
5362731 |
Use of piribedil derivatives and analogs for the treatment of hyperactive or unstable bladders
Piribedil is administered to patients to treat unstable or hyperactive bladders.
|
|
|
5350758 |
Piperidyl sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
The present invention relates to piperidyl sulfonamides and sulfoxamides which are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in patients in...
|
|
|
5348964 |
Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
The present invention relates to certain novel piperidyl ethers and thioethers which are useful as inhibitors of cholesterol biosynthesis and as agents which lower total serum cholesterol in...
|
|
|
5342838 |
Phenolic thioetheramides
The present invention relates to phenolic thioetheramides of the formula ##STR1## wherein R 1 and R 2 are tert-alkyl or phenyl, Alk 1 and Alk 2 are alkylene; X is sulfur or oxygen, m is 0, 1,...
|
|
|
5340801 |
Compounds having cholecystokinin and gastrin antagonistic properties
This invention relates to N-arylcarbamoyl proline analogues which are useful as cholecystokinin and gastrin antagonists, to pharmaceutical compositions including such proline analogues, and to...
|
|
|
5326688 |
Coating compositions for antistatic layers for photographic elements
A solvent mixture of 8 to 30 weight percent of n-propyl acetate 1-methoxy-2-propanol or cyclohexane, 50 to 55 weight percent of acetone and the balance methanol is employed in a coating composition...
|
|
|
5322852 |
Aminooxy piperidines as ornithine decarboxylase inhibitors
The invention relates to compounds of formula I ##STR1## wherein either R 1 is a radical of formula Ia, --(CH 2 ) n --O--NH 2 (Ia) in which n is 0 or 1, is hydrogen...
|
|
|
5314681 |
Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
The invention relates to a modification of electron spin resonance enhanced magnetic resonance imaging (ESREMRI) in which two magnetically responsive materials (contrast agents) are introduced into...
|
|
|
5306718 |
Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment
Pharmaceutically useful nitrogen containing cyclic oxime and amine substituted compounds of the following general Formulas I, II and III are disclosed: ##STR1## Specifically the compounds are...
|
|
|
5294430 |
Use of dithiocarbamates to treat myelosuppression
A process for preventing or ameliorating the myelosuppression which can occur in a mammal such as a human cancer patient being treated with a platinum-free antineoplastic drug is provided,...
|
|
|
5292750 |
Therapeutic agents
Compounds are described which are useful for lowering the activity of α 2 -PI, for the treatment of myocardial infarctions and cerebral infarctions, as urokinase secretion accelerators, as...
|
|
|
5290789 |
Penta and tetrasubstituted piperidines and compositions and method of treating psychosis
The invention is related to compounds, being useful in treating psychosis, of the formula: ##STR1## wherein: R 1 is hydrogen, lower-alkyl or phenyl-lower-alkyl; R 2 and R 4 are the same or...
|
|
|
5286733 |
Substituted 3-piperidinealkanoates and alkanones and compositions and method of use thereof
The invention is related to compounds, being useful in treating psychosis, of the formula: ##STR1## wherein: R 1 is hydrogen, lower-alkyl, phenyl-lower-alkyl, C 3 -C 7 -monocyclic...
|
|
|
5272155 |
(+)-2-methylpiperidine as modulator of cholinergic systems
Pharmaceutical compositions comprising a therapeutically effective amount of (+) 2-methylpiperidine and a pharmaceutically-acceptable carrier or diluent, as well as to a method of treating...
|
|
|
5270310 |
N-aminoalkyl amide inhibitors of protein kinase C
The present invention provides methods for inhibiting protein kinase C which comprise contacting protein kinase C with an inhibitory amount of a compound having the formula ##STR1## wherein R 1 is...
|
|
|
5266567 |
Halopropargylated cyclic quaternary ammonium compounds as antimicrobial agents
Antimicrobial compounds of the formula ##STR1## wherein R is selected from (A) (C 1 to C 20 ) straight or branched alkyl, optionally substituted with hydroxy, halogen, alkoxy, phenoxy, or...
|
|
|
5262427 |
3-substituted and optionally 1-substituted azacyclic or azabicyclic compounds, pharmaceutical compositions, thereof and their use as stimulants of cognitive functions
Azacyclic compounds selected from the group consisting of ##STR1## wherein R 1 is H or C 1 -6 -alkyl R 3 is ##STR2## wherein R' is C 3 -8 -alkyl, cyclopropyl, C 4 -8 -cycloalkyl, benzyl which...
|
|
|
5256657 |
Succinamide derivative matrix-metalloprotease inhibitors
Compounds having the structural formula ##STR1## wherein X is HONH or HO and especially wherein the carbon atom bearing CH 2 R 1 has the R-configuration, the carbon atom bearing CH 2 R 2 has...
|
|
|
5250542 |
Peripherally selective piperidine carboxylate opioid antagonists
3,4,4-trisubstitutedpiperidinyl-N-alkylcarboxylates and intermediates for their preparation are provided. These piperidine-N-alkylcarboxylates are useful as peripheral opioid antagonists.
|
|
|
5250292 |
Use of cyclic organic amines in dermatological compositions
The use of cyclic organic amines, as free radicals deactivators, in the preparation of cosmetic and dermatological compositions.
|
|
|
5250558 |
Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis
Substituted triazolinone, triazolinethione, and triazolinimine compounds of formula (I) are as neurotensin II antagonists. These compounds have the general formula: ##STR1##
|
|
|
5250194 |
N-dodecyl heterocyclic compounds useful as industrial microbicides and preservatives
A method for inhibiting the growth of microorganisms in which an N-dodecyl heterocyclic compound in an amount effective to inhibit the growth of microorganisms is contacted with an aqueous system...
|
|
|
5236922 |
Method for treating depression using 1-(aminophenyl)-2-aminopropanone derivatives
The present invention relates to the preparation of new 1-(aminophenyl)-2-aminopropanone derivatives of the general formula: ##STR1## in which X is NH 2 , Y is H or a halogen atom, Z is H or a...
|
|
|
5219866 |
Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its preparation
Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its preparation. This compound is useful for the treatment of cancer.
|
|
|
5217979 |
Substituted alkyl piperidines
The present invention relates to a group of compounds which are novel substituted alkyl piperidines and which act to inhibit the synthesis of cholesterol in mammals and in fungi.
|
|
|
5215998 |
Alkylphosphonothioate insecticides
Compounds and compositions containing alkylphosphonothioates, for insecticidal control, particularly for use as soil and/or foliar insecticides, having the formula. ##STR1## in which R is C 1 -C 3...
|
|
|
5214052 |
Method for dissolving arginineamides and pharmaceutical compositions containing them
A method for dissolving an arginineamide of the invention comprising dissolving N 2 -arylsulfonyl-L-arginineamide having the general formula (I) ##STR1## wherein R 1 represents a (2R,...
|
|
|
5210089 |
D-rhamnono-1,5-lactone
The novel D-rhamnono-? ,5-lactone and a novel method of synthesis of said compound from the monoacetonide of L-gulono-γ-lactone is disclosed. D-Rhamnono-1,5-lactone is a potent inhibitor of α-and...
|
|
|
5196439 |
Piperidine compounds useful to treat cerebrovascular diseases
A cyclic amine is defined by the formula: ##STR1## in which A is naphthyl, phenyl, quinolyl or alkyl, X is a group containing carbonyl, n is 2 or 3 and B is alkyl, halogen, phenyl or --YZ, Y being...
|
|
|
5192774 |
Substituted acetamide derivatives, process for their preparation and antiulcer drug containing same
A substituted acetamide derivative of general formula (I): ##STR1## [in which Y represents as piperidino group, 1-pyrrolidinyl group or 3-hydroxy-1-pyrrolidinyl group, and Z represents a group...
|
|
|
5187102 |
Inhibitors for the anticoagulant pretreatment of blood samples
Meizothrombin- and thrombin-inhibiting inhibitors which do not bind bivalent cations and which are used for the anticoagulant pretreatment of blood samples to be used in the determination of the...
|
|
|
5185335 |
N-(4-piperodinyl)(dihydrobenzofuran or dihydro-2H-benzopyran) carboxamide derivatives
Piperidine derivatives of formula ##STR1## wherein A is a radical of formula ##STR2## wherein one or two hydrogen atoms in said radicals (a-1) to (a-3) may be replaced by a C 1 -6 alkyl radical; ...
|
|
|
5173487 |
Mevinic acid derivatives
Antihypercholesterolemic activity, due to competitive inhibition of HMG CoA reductase, is exhibited by a compound of the formula ##STR1## m is 0 to 3; R is selected from: (1) alkyl; (2)...
|
|
|
5164388 |
Heterocyclic peptide renin inhibitors
A renin inhibiting compound of the formula ##STR1## wherein X is N, O or CH; R 1 is absent or a functional group; A and L are independently selected from absent, CO, SO 2 and CH 2 ; D is...
|
|
|
5153205 |
Method to reduce introacular pressure without causing miosis
Topical administration of a cholinomimetic agent, such as pilocarpine, in combination with a cholinergic M 3 receptor antagonist, such as 4-diphenyl-acetoxy-N-methylpiperidine, to the eye of a...
|